Hillstream BioPharma Statistics Share Statistics Hillstream BioPharma has 17.6M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 17.6M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 11.46M Failed to Deliver (FTD) Shares 2,782 FTD / Avg. Volume 0.41%
Short Selling Information Short Interest n/a Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) n/a
Valuation Ratios The PE ratio is -0.03 and the forward
PE ratio is null.
Hillstream BioPharma's PEG ratio is
0.
PE Ratio -0.03 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0.03 P/FCF Ratio -0.03 PEG Ratio 0
Financial Ratio History Enterprise Valuation Hillstream BioPharma has an Enterprise Value (EV) of -10.7M.
EV / Sales 0 EV / EBITDA 1.13 EV / EBIT 1.47 EV / FCF 1.47
Financial Position The company has a current ratio of 6.03,
with a Debt / Equity ratio of 0.
Current Ratio 6.03 Quick Ratio 6.03 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 572.87
Financial Efficiency Return on Equity is -102.06% and Return on Invested Capital is -103.55%.
Return on Equity -102.06% Return on Assets -85.13% Return on Invested Capital -103.55% Revenue Per Employee n/a Profits Per Employee $-9.32M Employee Count 1 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 32.6% in the
last 52 weeks. The beta is 0, so Hillstream BioPharma's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change 32.6% 50-Day Moving Average 0.22 200-Day Moving Average 0.56 Relative Strength Index (RSI) 41.23 Average Volume (20 Days) 684,778
Income Statement
Revenue n/a Gross Profit n/a Operating Income -9.46M Net Income -9.32M EBITDA -9.46M EBIT -9.34M Earnings Per Share (EPS) -7.14
Full Income Statement Balance Sheet The company has 10.94M in cash and 0 in
debt, giving a net cash position of 10.94M.
Cash & Cash Equivalents 10.94M Total Debt n/a Net Cash n/a Retained Earnings -24.7M Total Assets 3.17M Working Capital 1.76M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -7.3M
and capital expenditures 0, giving a free cash flow of -7.3M.
Operating Cash Flow -7.3M Capital Expenditures n/a Free Cash Flow -7.3M FCF Per Share -5.59
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
